0
0
6/19/23 at 9:46pm
Organization
American Council on Science and Health
44 words
0
Comments
Pfizer has just completed phase 3 trials of a new antibiotic active against highly resistant Gram-negative infections. A real superbug fighter. But what too so long?
You are the first to view
https://www.acsh.org/news/2023/06/19/new-weapon-against-superbugs-17152
Create an account
or login to join the discussion